Below is our recent interview with Keri Fraser, Strategic marketing advisor at Grey Slide Imaging:
Q: Could you provide our readers with a brief introduction to your company?
A: Grey Slide Imaging (GSI) technology empowers our customers to reveal meaningful insights into disease and treatments. We have developed a digital pathology imaging system providing; digital slide scanning, live image viewing, workflow management software, advanced AI analysis, digital image storage, and remote sharing solutions for pathologists. Our products remove barriers to leveraging digital pathology and help bridge the gap between science and improving patient outcomes.
Q: Any highlights on your recent announcement?
A: We recently announced a partnership with University Massachusettes, Boston. This partnership and licensing of patented imaging techniques brings the Grey Slide solution one step closer to achieving our goals of bringing accessible digital pathology to the world.
Q: Can you give us more insights into your offering?
A: The future of pathology is digital, and the digital pathology offering will drastically improve global access to healthcare. With a worldwide shortage of pathologists, the ability for physicians to effectively diagnose and stage diseases and therefore provide effective patient treatment is diminished. Transforming pathology from analog microscope viewing to digitally scanned images will bring the efficiencies needed to close the gap between supply and demand for pathologist expertise and time.
Q: What can we expect from your company in next 6 months? What are your plans?
A: Watch for Grey Slide’s exciting announcements in the coming months with its game changing end to end solution for transforming the pathology lab to digital.
Q: What is the best thing about your company that people might not know about?
A: Grey Slide is truly global and has a global mission at heart. Our developers and medical experts collaborate from India to Canada and our partnerships span the USA to Europe. Most importantly our vision for making digital pathology available around the globe truly canters on ensuring that lower and middle income countries have the same access to digital pathology that the developed world is moving to.